Table V.
Groups | Median | IQR | Differences from 21th daya |
---|---|---|---|
Sham (n=9) | 119.92 | 14.15 | Z=2.301; P=0.021 |
PCOS control (n=9) | 194.52 | 18.91 | Z=0.059; P=0.953 |
Merformin (n=8) | 106.64 | 53.97 | Z=2.521; P=0.012 |
Metformin + PDE4i (n=10) | 97.12 | 17.52 | Z=2.803; P=0.005 |
Wilcoxon signed rank test results. PDE4i, phosphodiesterase 4 inhibitor; PCOS, polycystic ovary syndrome; IQR, interquartile range.